Background-Diastolic dysfunction (DD) is associated with adverse cardiovascular outcomes. We studied the impact of an exercise-based lifestyle intervention on the evolution of DD in patients with type 2 diabetes mellitus (T2DM) and prospectively investigated the clinical correlates of DD progression. Methods and Results-A total of 223 outpatients with T2DM were randomized to supervised exercise-based lifestyle intervention (initial gym-based program and lifestyle and diet advice followed by telephone-guided supervision) or usual care. Patients underwent echocardiographic assessment of diastolic function and metabolic and clinical evaluation at baseline and 3 years. Changes in prevalence and evolution of DD were assessed and correlations sought with clinical and metabolic variables. DD was present in 50% of patients at baseline and 54% at 3 years, with no difference between the usual care and intervention groups (60% versus 48%, Pϭ0.10). Abnormal DD at the final visit was independently associated with older age and a decrease in peak oxygen consumption over time (PϽ0.05). There was no impact on glycemic control or exercise capacity. In a subanalysis restricted to patients who finished the full 3-year follow-up, control subjects were independently associated with DD at 3 years (␤ϭ0.90; odds ratio, 2.46; Pϭ0.034), with the only other independent correlate being older age (␤ϭ0.05; odds ratio, 1.06; Pϭ0.019). Conclusions-Despite being efficacious in the subgroup who completed 3 years of exercise-based lifestyle intervention, randomization to this program was not effective in reducing progression of subclinical DD in patients with T2DM, which may reflect the recognized difficulty of adherence to prolonged exercise intervention. Clinical Trial Registration-URL: http://www.anzctr.org.au. Unique identifier: ACTRN12607000060448. (Circ Heart Fail. 2011;4:441-449.) 
P atients with type 2 diabetes mellitus (T2DM) are more susceptible to developing heart failure after a myocardial insult such as infarction, 1 and those with heart failure have an especially poor prognosis compared to patients with heart failure without diabetes. 2 These observations may reflect the importance of underlying subclinical LV dysfunction, which has been well documented in patients with T2DM. 3 Although comorbidities such as ischemia and hypertension probably explain some of the myocardial dysfunction associated with T2DM, studies of T2DM without these conditions have suggested a direct adverse effect of diabetes on myocardial function. 4 
Clinical Perspective on p 449
Diastolic dysfunction (DD) is a common complication of T2DM that is independently associated with poor cardiovascular outcomes. 5, 6 In patients presenting with diastolic heart failure, diabetes is common and associated with increased ventricular stiffness. 7, 8 Despite increasing cross-sectional data, information regarding the evolution of DD in T2DM or the factors influencing its progression is limited, 9 and no previous study has demonstrated the ability to alter the progression of DD in T2DM. Exercise has beneficial effects on glycemic control, lipids, weight loss, blood pressure, and other vascular parameters in T2DM, but there are few data related to its myocardial effects. 10 The present study describes the impact of an exercise and lifestyle intervention on DD at 3 years and, secondly, investigates the progression and clinical correlates of DD in a prospectively evaluated group of patients with T2DM. Secondary end points of glycemic control, exercise capacity, and other markers of myocardial function also were assessed.
Methods

Patient Selection
This prospectively evaluated patient population (from 2003 to 2006) comprised 250 patients with T2DM who were identified and referred to the study coordinators by clinical and research staff of a tertiary hospital diabetes clinic. Recruited patients were aged 18 to 75 years, had a left ventricular (LV) ejection fraction Ͼ50%, and had myocardial ischemia excluded by stress echocardiography. Patients also were excluded if they had more than mild valvular disease. Patient flow through the study is shown in Figure 1 . Of the initial 250 assessed for eligibility, 27 were excluded before randomization most commonly because of detection of myocardial ischemia (nϭ16). Randomization (performed by an independent statistician using random number generator software) led to 111 patients being assigned to an intensified program of dietary advice and supervised exercise and 112 to usual care. After randomization, 18 patients withdrew from the study because of new ischemia (nϭ1), loss to follow-up (nϭ14 [of whom 5 having moved away]), and technical problems with imaging assessment of diastolic function (nϭ3). Therefore, 186 (83%) patients (intervention, nϭ94; usual care, nϭ2) underwent assessment after 33Ϯ7 months (range, 12 to 46 months). The study was approved by the local institutional review committee, and all subjects gave written informed consent.
Exercise Intervention
Patients receiving the intervention were randomized to a 2-stage supervised exercise program 11 that comprised an initial 4-week gym-based exercise program of 2 1-hour exercise sessions per week, supervised by an exercise physiologist, with a further 30 minutes of home-based exercise. Each individualized program sought to provide at least moderate exertion (12 to 13 on the Borg 20-point scale) using a combination of both aerobic and resistance exercise. Aerobic exercise was customized to patient preference and ability and included cycling, jogging, walking, stepping, or rowing. Resistance exercise initially was gym based using machine or free weights, with transition to home-based resistance training with Thera-Bands and FitBALLs. The subsequent home-based program was supported by telephone counseling, with an emphasis on maintenance and improvement. This contact was initially weekly and then once every 2 weeks for 3 months, with monthly follow-up thereafter. Data regarding exercise frequency and intensity were available for a limited number of patients after 3 years (nϭ117). Activity was assessed using the Active Australia Survey, a validated physical activity questionnaire. 12 Total weekly minutes spent in walking, moderate activities, and vigorous other activities were collected. Minutes of total activity level was calculated walkingϩmoderate other activityϩ(vigorous other activityϫ2). 12 In addition, patients received guideline-based general dietary advice to aim for a balanced diet consisting of a target intake of 50% carbohydrates, Ͻ35% fat, and an equal ratio of polyunsaturated:monounsaturated:saturated fat. All patients, irrespective of treatment group, received standard risk factor modification by their treating physicians.
Biochemistry
All patients underwent standard biochemical assessment, including fasting lipids (total cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides) and assessment of glycohemoglobin.
Echocardiography
Conventional 2D echocardiography at rest was performed at baseline and 3 years. Evaluation of LV volumes and ejection fraction was performed using the Simpson biplane method. LV mass index (LVMI) was assessed according to the method of Devereux et al. 13 Transmitral flow was interrogated by pulsed wave Doppler echocardiography, with measurement of early (E) and late waves. Pulsed wave tissue Doppler echocardiography was used to measure the early diastolic relaxation velocity (Em) at the septal mitral annulus. The E/Em ratio was used as an estimate of LV filling pressure. 14 Left atrial volume was measured using the area-length method and indexed to body surface area (left atrial volume index). Tissue velocity-based peak longitudinal strain and strain rate were measured off line using specialized software (Echopac BT 2008; GE Medical Systems, Milwaukee, WI) and reported as the average of 6 basal segments from the 3 standard apical views. 15 Echocardiographic parameters were measured off line in batches by an observer blinded to treatment allocation. All repeated measures were made with the observer blinded to previous results.
Classification of Diastolic Function
Patients were categorized into groups of normal diastolic function, delayed relaxation, or pseudonormal or restrictive diastolic filling. Delayed relaxation was defined as a mitral E-wave deceleration time greater than published age-specific normal values (meanϩ2 SD). 16 For those with normal E-wave deceleration times, patients were classified as having pseudonormal filling if they had evidence of elevated filling pressure manifested as 1 of the following criteria: (1) E/EmϾ15 or (2) E/EmϾ8 and Յ15 and left atrial volume index Ն34 mL/m 2 . 17, 18 Restrictive filling was defined if the mitral E-wave deceleration time was Ͻ140 ms, with at least 1 other criterion suggesting elevated filling pressures as outlined previously. 6 Evolution of DD was assessed by examining the change in diastolic function category.
Cardiopulmonary Testing
All patients underwent a maximal (symptom-limited) ramped treadmill stress test (based on the modified Naughton protocol) with assessment of peak oxygen consumption (VO 2 ) at exhaustion by indirect calorimetry (Vmax29c; Sensormedics; Yorba Linda, CA). Regular (every 2 minutes) assessment of blood pressure and continuous 12-lead electrocardiographic monitoring were performed throughout (CASE 14; GE Medical Systems). Stress echocardiography was performed in all patients immediately postexercise to exclude the presence of inducible myocardial ischemia (Vivid 7; GE Medical Systems).
Statistical Analysis
Measures of grouped data are reported as meanϮSD. Sample size was calculated using data from prior pharmaceutical studies. 11, 19 This was based on an anticipated increase in myocardial diastolic tissue velocity of 1.1 cm/s (baseline 5.5Ϯ1.7 cm/s), with 56 patients per group to provide 90% power. Anticipated drop out was accounted for by randomizing 112 patients per group. Analysis was by intention to treat, and patients with missing 3-year data had their last measure carried forward: A 2-year assessment was used in 45/186 (24%) patients, and a 1-year assessment was used in 12/186 (7%). Normality of data were assessed using the Kolmogorov-Smirnov test and plots. Analysis of differences between groups was performed using t test and ANOVA with Bonferroni correction for multiple comparisons. ANCOVA was performed to assess influence of covariates. Nonparametric tests (Mann-Whitney) were used for nonnormally distributed data, and 2 were used for categorical comparison. Logistic regression analysis was used to assess categorical outcomes of interest (ie, presence of DD). Variables were included in models according to univariate significance (PϽ0.1), clinical significance, or both. Statistical significance was defined as PՅ0.05. Analysis was performed using SPSS version 17 (SPSS Inc, Chicago, IL) statistical software.
Results
Baseline Patient Characteristics
Of the 186 patients who underwent follow-up (mean age, 56Ϯ10 years; male sex, 55%), most were overweight and normotensive with a duration of diabetes of 6.3Ϯ6.5 years. Patients who were lost to follow-up (nϭ37) were more overweight and had lower exercise capacity but had similar baseline characteristics to the remainder of the study group (Table 1) .
The baseline characteristics of randomized patients are shown in Table 2 . Most patients were taking oral hypoglycemic agents. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers were used in about half of the patients. In this group of patients with diabetes without ischemia, the rate of ␤-blocker use was Ͻ10%. Patients randomized to exercise intervention had higher baseline blood pressure, slightly lower baseline peak VO 2 , and greater Em than those assigned to usual care. There were no other significant baseline differences between the 2 groups.
Baseline Diastolic Function
Diastolic function was abnormal in 93 (50%) patients at baseline; only 1 patient had a restrictive filling pattern. Patients with pseudonormal filling were older than those with either delayed relaxation or normal diastolic filling (Table 3) . LVMI was significantly higher in patients with delayed relaxation and pseudonormal filling than in patients with normal diastolic function. This association was independent of blood pressure. Myocardial strain was significantly worse in patients with pseudonormal filling than in those with delayed relaxation. As expected, at baseline there were similar proportions of DD between patients who were randomized either to usual care or to exercise intervention ( Figure 2 ). Table 4 outlines the influence of the intervention on end points of glycemic control, lipids, and myocardial markers. There was no significant change in weight or blood pressure between the groups over follow-up. Both groups showed an increase in exercise capacity after 3 years (Pϭ0.97). The primary end point (tissue Em) showed a deterioration in the intervention group, with this result probably reflecting the baseline differences in this parameter (Pϭ0.78 after correction for baseline Em). There was no correlation at baseline between Em and peak VO 2 ; however, at the final visit, higher E/Em (LV filling pressure) was associated with lower peak VO 2 (rϭϪ0.34, PϽ0.001). There were no other significant changes in clinical or metabolic parameters between the 2 groups at 3 years.
Influence of Intervention on Clinical Factors, Metabolic Parameters, and Markers of Myocardial Function
When analysis was restricted to patients who completed the 3-year follow-up (nϭ129), the results were similar, with no significant difference between the treatment groups with regard to hemodynamic, metabolic, or myocardial parameters. There were no significant baseline differences between the intervention and usual care groups in weekly walking time (163Ϯ174 versus 204Ϯ210 minutes, Pϭ0.17) or total activity time (401Ϯ512 versus 424Ϯ439 minutes, Pϭ0.76). After 3 years, there were no differences between the intervention and usual care groups for change in walk time (27Ϯ192 versus 28Ϯ264 minutes, Pϭ0.99) and change in total activity time (89Ϯ661 versus 146Ϯ497 minutes, Pϭ0.60).
Changes in Diastolic Category With Time
The proportion of patients with DD slightly increased to 54% at 3 years (McNemar test, Pϭ0.51). At the final visit, 58 (31%) patients showed progression of diastolic function from baseline and 49 (26%) improved (Figure 3) . The proportion of patients with DD increased nonsignificantly in the control arm (60%) and decreased in the intervention group (48%) (Figure 2 ). When the 3 categories of change in DD (im-proved, no change, worsened) were compared between randomized groups, no significant differences ( 2 Pϭ0.35) were found. Using baseline variables of age, duration of diabetes, treatment group, baseline glycohemoglobin, change in weight, change in systolic blood pressure, change in LVMI, and change in peak VO 2 , the only significant predictor of DD was increased age (Pϭ0.033) and a reduction in peak VO 2 (Pϭ0.016) ( Table 5 ).
In a subanalysis restricted to patients who completed 3 years of follow-up, there was no significant difference in baseline prevalence of DD (51% versus 49%, Pϭ0.79), with a trend to increased DD in the control group (66% versus 49%, Pϭ0.06). Membership of the control group (␤ϭ0.90; odds ratio, 2.46; Pϭ0.034) was a significant independent correlate of the presence of DD at 3 years, with the only other independent correlate being older age (␤ϭ0.05; odds ratio, 1.06; Pϭ0.019). Table 6 summarizes baseline and changes of various characteristics in patients who changed category of diastolic function. Those who had improved diastolic function had higher LVMI at baseline. However, there were no other significant differences between groups, including no significant differ- Data are presented as meanϮSD or n (%). ACEI indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; Em, early diastolic relaxation velocity; LAVI, left atrial volume index; LVMI, left ventricular mass index. Other abbreviations as in Table 1 .
Correlates of Change in Diastolic Function
ences in the rate of use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. There also was no difference within subjects using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with regard to change in diastolic function over time.
Discussion
This study confirms that abnormal diastolic function is common in T2DM and confirms that increased LVMI is a correlate of worse diastolic functional class in this condition, independent of blood pressure. In this randomized study of a program of exercise-based lifestyle intervention over 3 years, the intention-to-treat analysis was negative, but in the patients complying with therapy over 3 years, the intervention pro-gram had an independent positive effect on the development or progression of abnormal diastolic function in T2DM.
Prevalence of DD in T2DM
DD is a common finding in patients with T2DM, with reported prevalence rates as high as 47% to 75% in asymptomatic patients, even in the absence of significant coronary artery disease. 20, 21 In the present analysis, the prevalence of any DD was 50%, a rate consistent with previous studies in Data are presented as meanϮSD. Abbreviations as in Tables 1 and 2. asymptomatic, normotensive populations without ischemic heart disease. 20, 21 Specifically, the proportion with delayed relaxation (28%) and pseudonormal filling (21.5%) seen in our study is similar to previous reports of 30% and 17%, respectively. 20, 21 The current study population was relatively healthy, with mean blood pressures in the normal range, mildly elevated glycohemoglobin, and a mean duration of diabetes of Ϸ6 years. The group was, however, significantly overweight, with a mean body mass index similar to that in previous studies. 20 As a marker of cardiovascular risk, the association of DD with adverse outcomes has been well documented. 6, [22] [23] [24] Redfield et al 6 showed that even mild DD is associated with a marked increase in all-cause mortality independent of age, sex, and ejection fraction. It was also noted that patients with diabetes had a higher rate of DD than those without diabetes, with the degree of DD also associated with increased LVMI.
Mechanisms of DD in T2DM
Cross-sectional studies have previously associated diabetes with increases in LV mass, independent of common comorbidities, such as obesity and hypertension, with the combination of these conditions leading to further increases than either alone. 4, 25 Factors implicated in these findings have included myocyte hypertrophy, increased myocardial collagen deposition, and interstitial fibrosis. 9 The role of diabetic microangiopathy is supported by the observation of impaired coronary flow reserve in T2DM with and without hypertension; increasing LVMI is the main independent predictor of this association. 26 Several metabolic abnormalities have been postulated to play a role in the development of diabetic myocardial dysfunction. Impaired glucose use and increased free fatty acid oxidation have been implicated to result in abnormal calcium homeostasis, decreased cardiac efficiency, lipotoxicity, and mitochondrial damage. 27 Disordered cardiac autonomic function also has been independently associated with DD in patients with T2DM, 28 possibly by stimulation of the renin-angiotensin-aldosterone system, direct toxic effects on the myocardium, or both. Neurohormonal alterations 29 and the effects of protein glycation are likely to be involved, with the effect of advanced glycation end products suggested as a possible common pathway for both myocardial and vascular abnormalities. 30
Impact of Lifestyle Intervention and Evolution of DD
Studies examining potential therapeutic strategies for DD or diastolic heart failure have been largely absent or disappointing, yet the prognosis associated with these conditions remains poor. 31 Exercise in T2DM has been associated with beneficial effects on glycemic control, weight loss, blood pressure, vascular function, and lipid profile. 32 Although animal studies suggest beneficial effects on cardiac metabolism and myocardial stiffness, the myocardial effects of exercise in T2DM have been less well studied in humans. Woodiwiss et al 33 showed that increased diastolic stiffness in diabetic rats was associated with enhanced formation of advanced glycation end products of myocardial collagen and then showed that exercise attenuated the development of abnormal diastolic function, possibly by effects on active rather than passive myocardial properties. Exercise training may attenuate the perturbations in intracellular calcium handling that are present in diabetic myocardium. 34 In the present clinical study, significant beneficial effects were not observed, which suggests that a prolonged exercise-based lifestyle intervention has little effect on the progression of DD, exercise capacity, or metabolic parameters such as glycemic control. This finding may relate to the well-recognized difficulty in maintaining patient adherence with lifestyle modifications over extended periods of time. However, the fact that a reduction in exercise capacity over time was independently associated with the presence of DD at 3 years is supportive of the link between abnormal diastolic function and functional limitation. When the analysis was restricted to patients who completed the full 3-year follow-up, older age and involvement in the usual care group were significantly and independently associated with the prevalence of DD at Tables 1 and 2. the final visit, suggesting a possible attenuating effect of the lifestyle intervention on progression of DD. Furthermore, despite a trend to increased activity levels with the intervention, the mean differences in reported activity times were not significant between the 2 groups. Thus, patient adherence was a significant hurdle for this lifestyle intervention program, just as it was in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) study. 35 Although there is limited information available, there is some prior evidence to suggest that changes in weight have beneficial effects on diastolic measures of myocardial function. 36 In the present study, the lack of significant weight loss in the treatment group may have contributed to the failure of the intervention to show significant beneficial effects on diastolic function.
Implications for Clinical Management
The optimal amount and type of regular exercise required to exert myocardial benefits is not well defined. There is some suggestion that benefits may be limited to those who participate in moderate to vigorous physical activity. 11 Based on demonstrated improvements in glycemic control and other cardiovascular risk factors, recent guidelines now suggest at least 150 minutes per week of moderate-intensity exercise as a class 1A recommendation for patients with T2DM. 32 Although these goals seem attainable with intensive shortterm lifestyle interventions, the results of this study suggest that implementation of these recommendations into clinical practice over the longer term may prove difficult.
Limitations
A potential limitation of the present study is the fact that enrolled patients had relatively good glycemic control; thus, progression may be greater in patients with less wellcontrolled disease. Furthermore, after an initial period of gym-based exercise intervention, the ongoing intervention was home based with subsequent regular phone support from an exercise physiologist. It is possible that more-intensive Data are presented as meanϮSD or n (%). Abbreviations as in Tables 1 and 2. supervision may have resulted in greater efficacy of the intervention. However, the feasibility of such an approach in clinical practice requires further study. Crossover to better lifestyle choices in the usual care group also may have contributed to failure to identify a significant difference with the intervention. The fact that both groups improved their peak VO 2 by a similar amount may support this possibility. Exercise intervention is difficult to blind from supervising physicians and scientists and is a limitation of all similar studies.
Conclusions
The present study confirms that DD is common in patients with T2DM. Although an extended, supervised, and homebased exercise-lifestyle intervention may have a favorable effect on the evolution of DD, the lack of impact of this intervention on an intention-to-treat basis attests to the challenges of maintaining adherence to this form of therapy. Given the adverse prognosis associated with DD and the lack of evidence-based pharmacotherapy, these findings reinforce the importance of further investigations to identify potential treatment options for patients with T2DM who have evidence of myocardial dysfunction.
